Personalised treatment may help some liver cancer patients

A more personalised treatment for people with a type of metastatic liver cancer - hepatocellular carcinoma - may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers. Hepatocellular carcinoma (HCC) is the number three cause of cancer deaths in the world...

Read the whole article on

More from